Jump to ContentJump to Main Navigation
Navigate here

Open Medicine: Topical Issue on Cancer Biomarkers

 ◄ Back to journal

 

GUEST EDITOR

Qian Liu, Tianjin Medical University General Hospital, China
 

DESCRIPTION

At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes.  Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Clinical molecular diagnostics and biomarker discoveries in oncology are advancing rapidly as we begin to understand the complex mechanisms that transform a normal cell into an abnormal one. Recent advances in multiplex genotyping technologies and high-throughput genomic profiling by next-generation sequencing make possible the rapid and comprehensive analysis of the cancer genome of individual patients even from very little tumor biopsy material. Thus, all aspects of cancer biomarkers and including original research (clinical trials and translational or basic research), reviews, and opinion pieces are encouraged, thus contributing crucially to the development of cancer biomarkers.

 

HOW TO SUBMIT

Please contact Guest Editor Dr Qian Liu liuqian@lungca.org, and Managing Editor (Magdalena.Wierzchowiecka@degruyteropen.com) to let know, you are going to submit a paper to Special Issue.

After that feel free to register at our paper processing system, and submit your paper: www.editorialmanager.com/openmed

All papers will go through the Open Medicine high standards, quick, fair and comprehensive peer-review procedure. Instructions for authors are available here.

In case of any questions please contact Guest Editor (liuqian@lungca.org) or Managing Editor (Magdalena.Wierzchowiecka@degruyteropen.com).

As an author of Open Medicine you will benefit from:

  • transparent, comprehensive and fast peer review
  • efficient route to fast-track publication and full advantage of DGO e-technology;
  • free language assistance for authors from non-English speaking regions.